{"product_id":"global-stem-cells-market-growth-status-and-outlook-2023-2029","title":"Global Stem Cells Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Stem Cells Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eStem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Stem Cells Industry Forecast” looks at past sales and reviews total world Stem Cells sales in 2022, providing a comprehensive analysis by region and market sector of projected Stem Cells sales for 2023 through 2029. With Stem Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stem Cells industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Stem Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Stem Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Stem Cells market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stem Cells and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stem Cells.\u003c\/p\u003e\n\n\u003cp\u003eThe global Stem Cells market size is projected to grow from US$ 2693.1 million in 2022 to US$ 5700.6 million in 2029; it is expected to grow at a CAGR of 11.3% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eStem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Stem Cells market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003c\/p\u003e\n\n \u003cp\u003eStem Cell Storage\u003c\/p\u003e\n\n \u003cp\u003eStem Cell Pharmaceutical and Treatment\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003c\/p\u003e\n\n \u003cp\u003eBlood Disease\u003c\/p\u003e\n\n \u003cp\u003eCancer\u003c\/p\u003e\n\n \u003cp\u003eAutoimmune Disease\u003c\/p\u003e\n\n \u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003c\/p\u003e\n\n \u003cp\u003eAmericas\u003c\/p\u003e\n\n \u003cp\u003eUnited States\u003c\/p\u003e\n\n \u003cp\u003eCanada\u003c\/p\u003e\n\n \u003cp\u003eMexico\u003c\/p\u003e\n\n \u003cp\u003eBrazil\u003c\/p\u003e\n\n \u003cp\u003eAPAC\u003c\/p\u003e\n\n \u003cp\u003eChina\u003c\/p\u003e\n\n \u003cp\u003eJapan\u003c\/p\u003e\n\n \u003cp\u003eKorea\u003c\/p\u003e\n\n \u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n \u003cp\u003eIndia\u003c\/p\u003e\n\n \u003cp\u003eAustralia\u003c\/p\u003e\n\n \u003cp\u003eEurope\u003c\/p\u003e\n\n \u003cp\u003eGermany\u003c\/p\u003e\n\n \u003cp\u003eFrance\u003c\/p\u003e\n\n \u003cp\u003eUK\u003c\/p\u003e\n\n \u003cp\u003eItaly\u003c\/p\u003e\n\n \u003cp\u003eRussia\u003c\/p\u003e\n\n \u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n \u003cp\u003eEgypt\u003c\/p\u003e\n\n \u003cp\u003eSouth Africa\u003c\/p\u003e\n\n \u003cp\u003eIsrael\u003c\/p\u003e\n\n \u003cp\u003eTurkey\u003c\/p\u003e\n\n \u003cp\u003eGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003c\/p\u003e\n\n \u003cp\u003eOsiris Therapeutics\u003c\/p\u003e\n\n \u003cp\u003eNuVasive\u003c\/p\u003e\n\n \u003cp\u003eChiesi Pharmaceuticals\u003c\/p\u003e\n\n \u003cp\u003eMedi-post\u003c\/p\u003e\n\n \u003cp\u003eJCR Pharmaceutical\u003c\/p\u003e\n\n \u003cp\u003eMolMed\u003c\/p\u003e\n\n \u003cp\u003ePharmicell\u003c\/p\u003e\n\n \u003cp\u003eAnterogen\u003c\/p\u003e\n\n \u003cp\u003eTakeda (TiGenix)\u003c\/p\u003e\n\n \u003cp\u003eCBR\u003c\/p\u003e\n\n \u003cp\u003eViaCord\u003c\/p\u003e\n\n \u003cp\u003eEsperite\u003c\/p\u003e\n\n \u003cp\u003eLifeCell\u003c\/p\u003e\n\n \u003cp\u003eCCBC\u003c\/p\u003e\n\n \u003cp\u003eVCANBIO\u003c\/p\u003e\n\n \u003cp\u003eBOYA LIFE\u003c\/p\u003e\n\n \u003cp\u003eBeike Biotechnology\u003c\/p\u003e\n\n \u003cp\u003eInternational Medical\u003c\/p\u003e\n\n \u003cp\u003eGlobal Cord Blood Corporation\u003c\/p\u003e\n\n \u003cp\u003eBeijing Health-Biotech Group\u003c\/p\u003e\n\n \u003cp\u003eABMD\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 124 Pages \/ MCW16225977","offer_id":47640101814578,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-stem-cells-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}